ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer

医学 指南 肺癌 阶段(地层学) 医学物理学 放射科 肺 放射外科 立体定向放射治疗 放射治疗 肿瘤科 内科学 病理 生物 古生物学
作者
Matthias Gückenberger,Nicolaus H. Andratschke,Karin Ute Dieckmann,Mischa S. Hoogeman,Morten Høyer,Coen Hurkmans,Stephanie Tanadini‐Lang,Eric Felix Lartigau,Alejandra Méndèz Romero,Suresh Senan,Dirk Verellen
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:124 (1): 11-17 被引量:367
标识
DOI:10.1016/j.radonc.2017.05.012
摘要

Background Stereotactic body radiotherapy (SBRT) has become the standard of care for medically inoperable patients with peripherally located, early stage non-small cell lung cancer (NSCLC), and for those refusing surgical resection. Despite the availability of national and international guidelines, there exists substantial variability in many aspects of SBRT practice. Methods The ESTRO ACROP guideline is based on a questionnaire covering all aspects of SBRT implementation and practice ( n =114 items). The questionnaire was answered by the 11 faculty members of the ESTRO course "Clinical practice and implementation of image-guided SBRT" and their 8 institutions. Results Agreement by >50% of the institutions was achieved in 72% of all items. Only 8/57 technologies and techniques were identified as mandatory for SBRT while 32/57 were considered as optional. In contrast, quality-assurance related elements were considered as mandatory in 12/24 items. A consensus of risk-adapted SBRT fractionation was achieved with 3×15Gy for peripherally located lesions and 4×12Gy (PTV D95-D99; D max <125% to <150%) for lesions with broad chest wall contact. For patients free from severe comorbidities and with favourable long-term OS expectancy, use of the maximum tolerated dose of 3×18Gy should be considered. Conclusions This ACROP guideline achieved detailed recommendations in all aspects of SBRT implementation and practice, which will contribute to further standardization of SBRT for peripherally located early stage NSCLC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CodeCraft的应助被Rittie21采纳,获得10
刚刚
Ren的应助被七月流火采纳,获得500
刚刚
今后的应助被福崽采纳,获得10
刚刚
Sxw发布了新的文献求助10
1秒前
1秒前
挚友发布了新的文献求助10
1秒前
Orange的应助被Mok采纳,获得10
2秒前
zxl666发布了新的文献求助10
2秒前
Dolin完成签到,获得积分10
2秒前
隐形曼青的应助被李金玉采纳,获得10
3秒前
Akim的应助被开朗书双采纳,获得10
4秒前
4秒前
4秒前
科研通AI6.2的应助被daigang采纳,获得10
4秒前
shichao完成签到,获得积分10
4秒前
5秒前
飞鱼完成签到 ,获得积分10
5秒前
5秒前
粟米完成签到 ,获得积分10
5秒前
5秒前
羊村长完成签到,获得积分10
5秒前
5秒前
实验狗发布了新的文献求助10
6秒前
zahngyacheng完成签到,获得积分10
6秒前
tomatoGG发布了新的文献求助10
6秒前
6秒前
英俊的铭的应助被岁月旧曾谙采纳,获得10
7秒前
胖橙发布了新的文献求助10
7秒前
Maestro_S的应助被charlesliu116采纳,获得10
7秒前
Lmx完成签到,获得积分20
7秒前
liaoyian完成签到,获得积分10
7秒前
7秒前
余偲完成签到,获得积分20
8秒前
suzy完成签到,获得积分10
8秒前
8秒前
zzzyf14138完成签到,获得积分10
8秒前
8秒前
qq完成签到,获得积分10
9秒前
田様的应助被小刘采纳,获得10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160268
求助须知:如何正确求助?哪些是违规求助? 9555328
关于积分的说明 21727231
捐赠科研通 7750062
什么是DOI,文献DOI怎么找? 3427353
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471707